856165-82-7

Usage

Uses

Used in Pharmaceutical Industry:
4-Chloro-3-isopropoxybenzoic acid is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs. Its anti-inflammatory and analgesic properties make it particularly useful in the formulation of medications aimed at treating pain and inflammation.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Chloro-3-isopropoxybenzoic acid serves as a crucial component in the creation of agrochemicals, potentially enhancing crop protection and management strategies by contributing to the development of effective pesticides or other agricultural chemicals.
Used in Organic Compounds Production:
4-Chloro-3-isopropoxybenzoic acid is utilized as an intermediate in the production of other organic compounds, highlighting its versatility and importance in organic chemistry and the synthesis of a wide range of chemical products.

Upstream product

• 1394977-52-6 isopropyl 4-chloro-3-isopropoxybenzoate 
• 34113-69-4 4-chloro-3-hydroxybenzoic acid 

Downstream Products

• 1607024-67-8 ethyl 3-(4-chloro-3-isopropoxyphenyl)-3-oxopropanoate 
• 1607023-26-6 5-(4-chloro-3-isopropoxyphenyl)-3-(1-methyl-1H-pyrazol-5-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one 
• 1607024-68-9 5-(4-chloro-3-isopropoxyphenyl)-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile 
• 1607024-69-0 5-(4-chloro-3-isopropoxyphenyl)-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carboxamide 
• 1607024-70-3 (E)-5-(4-chloro-3-isopropoxyphenyl)-N-(1-(dimethylamino)ethylidene)-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carboxamide 
• 1607023-27-7 5-(4-chloro-3-isopropoxyphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

(3,4-DISUBSTITUTED)PROPANOIC CARBOXYLATES AS S1P (EDG) RECEPTOR AGONISTS

The present invention encompasses compounds of Formula A: A as well as the pharmaceutically acceptable salts thereof. The compounds are S1P1/Edg1 receptor agonists and thus have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity. The invention is also directed to pharmaceutical compositions containing such compounds and methods of treatment or prevention.